Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 13 (1) , 41
Abstract
There are limited data describing patients with moderate COPD exacerbations and evaluating comparative effectiveness of maintenance treatments in this patient population. The study examined COPD patients with moderate COPD exacerbations. COPD-related outcomes were compared between patients initiating fluticasone propionate-salmeterol 250/50 mcg (FSC) vs anticholinergics (ACs) following a moderate COPD exacerbation.Keywords
This publication has 15 references indexed in Scilit:
- Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurrent Medical Research and Opinion, 2011
- Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysisJournal of Medical Economics, 2011
- COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry programPrimary Care Respiratory Journal, 2010
- Is Pharmacologic Care of Chronic Obstructive Pulmonary Disease Consistent with the Guidelines?Population Health Management, 2010
- Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialThe Lancet, 2009
- Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespiratory Research, 2009
- Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasoneRespirology, 2009
- Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot studyPulmonary Pharmacology & Therapeutics, 2008
- Newly Diagnosed Chronic Obstructive Pulmonary DiseaseRespiration, 2003
- Disease Management Opportunities for Chronic Obstructive Pulmonary Disease: Gaps Between Guidelines and Current PracticeDisease Management, 2002